Korea Joongang Daily
Korea JoongAng Daily

Exclusive: Nearly 4,500 Teslas in Korea report battery errors, risking subsidy loss

Nearly 4,500 Teslas in Korea have experienced battery system malfunctions that prevent charging, with over half replaced with reused batteries rather than new ones, according to data acquired by the Korea JoongAng Daily.

2025-10-14

[단독] 한국 판매 테슬라 4500여대에서 배터리시스템 오류…절반은 ‘재제조 배터리’로 AS

2017년부터 한국에서 판매된 테슬라 차량 중 약 4500대에서 배터리 관리 시스템(BMS) 오류가 발생한 것으로 확인됐다. 또 배터리 오류 차량 수리 과정에서 절반 이상이 새 배터리가 아닌 폐배터리를 재조립해 만드는 일명 ‘리만배터리’(재제조 배터리)로 교체돼 소비자 반발이 확산되고 있다.

2025-10-14

Daejeon fire reveals weaknesses in disaster preparedness

A fire at a government data center in Daejeon on Friday paralyzed hundreds of state-run digital services, exposing weak disaster preparedness and sparking fears of a nationwide disruption of postal services ahead of the weeklong Chuseok holiday.

2025-09-28

SK On receives global safety and cybersecurity verification for battery management system

SK On became the first battery maker in Korea to earn an international Cyber Security Assessment (CSA) certification for its battery management system, the company announced Thursday.

2025-07-10

LG Energy, Qualcomm ink deal on novel battery management system

LG Energy Solution signed an agreement with Qualcomm to promote system-on-chip-based battery management system diagnostic solutions.

2024-12-23

Hyundai says its battery management system can prevent EVs from exploding

"Driving can be restricted as abnormal signals have been detected. Please call Hyundai Motor's emergency dispatch center for immediate support."

2024-08-15

Korean pharma shines at global health care conference

Korean biopharma shines at J.P. Morgan Healthcare Conference amid global industry optimism.

2024-01-09

Samsung Biologics orders hit 3 trillion won in historic milestone

Samsung Biologics has secured five biomanufacturing contracts, bringing the total of its 2023 orders to over 3 trillion won for the first time since its foundation.

2023-11-28

Samsung Biologics scores $242M Bristol-Myers Squibb deal

Samsung Biologics secures a $242 million contract manufacturing deal with Bristol-Myers Squibb, boosting its total contract wins this year to nearly $2.26 billion.

2023-09-18

Lotte Biologics to invest $3 billion in three new plants in Korea

Lotte Biologics will invest $3 billion to build three new plants in Korea by 2030, a major expansion plan in the contract manufacturing and development of bio products following the purchase of a plant in the United States.

2023-01-11